
PulsePet™
Advanced Inodilator for managing congestive heart failure in Dogs
Composition
Each chewable tablet contains:
- Pimobendan E.P : 1.25mg/ 2.5mg, 5mg, 10mg
Indications
- Management of mild, moderate, or severe (NYHA Class II–IV) congestive heart failure in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM).
- Delay of onset of congestive heart failure in dogs with preclinical (Stage B2) myxomatous mitral valve disease (MMVD).
Dosage and Administrations
- Recommended daily dose: 0.5 mg/kg body weight.
- Divide into two portions administered approximately 12 hours apart (morning and evening).
- Tablets are scored for accurate division.
Available at
- 1.25mg, 2.5mg, 5mg, 10mg
Prescribing Information
SkyEc Drugs and Pharmaceuticals Private Limited. © Copyrights 2010 – 2024. All rights reserved.
Trade marks are owned by or licensed to the SkyEc Drugs and Pharmaceuticals Pvt. Ltd. Registered in India.
Registered office: RAM- L1, Industrial Estate, Guindy, Chennai- 600032
Designed and Maintained by Defocus Studio